Cat.#: ACPP-1314
| Despition | Syndecan-1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg | inquiry |
| ACPP-1354 | PAX2 Blocking Peptide (AC1354) | 250 µg | inquiry |
| ACPP-1093 | Synthetic Nanodisc Human CCR5 Protein (AC1093) | 10 µg | inquiry |
| ACPP-1131 | Recombinant Human/Murine/Rat BDNF Protein (AC1131) | 50 µg | inquiry |
| ACPP-1058 | Recombinant Human TrkA Protein (Fc Tag) (AC1058) | 50 µg | inquiry |
| ACPP-1732 | Human CHRNA6 Protein (AC1732) | 5 µg | inquiry |
| ACPP-1234 | SOX10 Blocking Peptide (AC1234) | 250 µg | inquiry |
| ACPP-1290 | Insulin Receptor Blocking Peptide (AC1290) | 250 µg | inquiry |
| ACPP-1053 | Recombinant Mouse CD24 Protein (Fc Tag) (AC1053) | 50 µg | inquiry |
| ACPP-1545 | Human YWHAG Protein (AC1545) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.